
Retatrutide (LY3437943) is a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. Studied for its effects on glycemic control, body weight regulation, and hepatic lipid metabolism in metabo…
Retatrutide (LY3437943) is a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. Studied for its effects on glycemic control, body weight regulation, and hepatic lipid metabolism in metabolic research.